October 19, 2021
RFA-DA-22-033 - Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed)
National Institute on Drug Abuse (NIDA)
The purpose of this notice is to alert potential applicants to updated language in Funding Opportunity Announcement (FOA) RFA-DA-22-033, "Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed)". This change removes limiting language regarding the number of allowable submissions.
The following modification has been made to RFA-DA-22-033:
Currently Reads:
3. Additional Information on Eligibility
Number of Applications
Applicant organizations may submit more than one application, provided that each application is scientifically distinct.
The NIH will not accept duplicate or highly overlapping applications under review at the same time. This means that the NIH will not accept:
Applicant organization is allowed to submit only one application.
Modified to Read:
3. Additional Information on Eligibility
Number of Applications
Applicant organizations may submit more than one application, provided that each application is scientifically distinct.
The NIH will not accept duplicate or highly overlapping applications under review at the same time. This means that the NIH will not accept:
All other aspects of this FOA remain unchanged.
Sheba K. Dunston, EdD, MPH, CHES
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-1526
Email: Sheba.Dunston@nih.gov